Hancock Prospecting backs St George Mining with $20M
Hancock Prospecting has committed $20 million to St George Mining (ASX:SGQ) to advance a critical minerals project in Brazil.
Hancock Prospecting has committed $20 million to St George Mining (ASX:SGQ) to advance a critical minerals project in Brazil.
The Australian Securities and Investments Commission launched a verified website directory on its Professional Registers Search database to combat clone investment scams.
Acumen Pharmaceuticals (NASDAQ:ABOS) executed its exclusive option to develop and manufacture two Alzheimer's disease treatment candidates using the proprietary blood-brain barrier (BBB)-penetrating platform from JCR Pharmaceuticals (TSE:4552).
A group of investors led by the Public Investment Fund (PIF) filed for European Union antitrust clearance on Wednesday for the planned $55 billion purchase of Electronic Arts (NASDAQ:EA).
SpaceX (NASDAQ:SPCX) shares saw a 5% decline on Wednesday morning, ending a brief but intense winning streak that had seen the company's valuation climb to over $2 trillion.
Moody’s Ratings has expanded its Token Integration Engine to the Solana mainnet through Alpha Ledger, bringing machine-readable credit ratings to a major public blockchain.
World Liberty Financial (WLFI), the decentralised finance venture linked to US President Donald Trump and his family, is reportedly nearing a major regulatory milestone that could expand its role in the digital asset sector.
Elicio Therapeutics (NASDAQ:ELTX) announced promising clinical observations regarding its lead immunotherapy candidate, ELI-002 7P, in the treatment of metastatic mKRAS pancreatic ductal adenocarcinoma (PDAC).
West Texas Intermediate traded near $77 a barrel on Wednesday as markets reacted to a potential interim peace agreement between the United States and Iran that could allow Tehran to resume oil sales immediately.
MIRA Pharmaceuticals (NASDAQ:MIRA) announced on June 17, 2026, the submission of its Phase 2a clinical trial protocol (Protocol Mira-002) to the FDA.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy